4.2 Therapeutic Phlebotomy

Diagnostic sampling vs therapeutic removal

Diagnostic phlebotomy collects relatively small volumes for laboratory testing. Therapeutic phlebotomy (also called therapeutic venesection) removes a treatment dose of whole blood—commonly on the order of a unit (often about 450–500 mL in adults, adjusted by order, weight, and tolerance)—to change the patient’s physiology. The same nursing skill set (venous access, asepsis, monitoring) serves different goals:

Exam scenario cue: If the stem mentions polycythemia vera, hemochromatosis, prescribed “remove 500 mL,” or hematocrit goals, think therapeutic. If the stem mentions chemistry panels, cultures, or waste volume from a PICC, think diagnostic.

Primary indications

Polycythemia vera (PV)

Polycythemia vera is a myeloproliferative neoplasm with elevated red cell mass, often with JAK2 mutation context in clinical discussion. Elevated hematocrit increases blood viscosity and thrombotic risk. Therapeutic phlebotomy is a cornerstone of management to keep hematocrit below a clinician-defined target (commonly cited adult target around <45% in many PV protocols—always follow the current order and specialty guidance, not a memorized number alone).

Nursing focus: confirm recent CBC/hematocrit, verify the ordered removal volume and frequency, assess for symptoms of hyperviscosity (headache, visual changes) versus symptoms of over-removal (dizziness, tachycardia), and coordinate with cytoreductive therapy the patient may also receive.

Hereditary hemochromatosis and iron overload

In hereditary hemochromatosis, excess iron deposits in liver, heart, pancreas, and joints. Therapeutic phlebotomy removes red cells; the body then uses stored iron to make new hemoglobin, gradually lowering ferritin and transferrin saturation toward targets set by the clinician.

Iron studies context: Ferritin and transferrin saturation guide induction versus maintenance phlebotomy schedules. During induction, sessions may be frequent (e.g., weekly) until iron stores fall; maintenance is less frequent. The nurse does not independently change the schedule based on a single lab without an order, but should recognize when labs are missing, critically low hemoglobin appears, or the patient reports new fatigue that warrants holding and calling the provider.

Secondary erythrocytosis

Secondary erythrocytosis (e.g., chronic hypoxia, high altitude, certain tumors, testosterone therapy) elevates red cell mass from erythropoietin drive rather than a primary marrow neoplasm. Phlebotomy is not automatically indicated for every high hematocrit—clinicians weigh symptoms, thrombotic risk, and whether treating the underlying cause is preferable. When ordered, volume targets may be more conservative than in PV. Exam items may ask you to recognize that oxygen optimization or stopping an offending agent can be as important as removal.

Other occasional indications (e.g., porphyria cutanea tarda-related iron reduction in some pathways) appear less often on exams; know the big three patterns: PV, iron overload, secondary erythrocytosis when prescribed.

Volume targets and procedural principles

Orders should specify:

• Volume to remove (mL) or “one unit” with facility definition
• Frequency and hematocrit/ferritin parameters for hold or proceed
• Replacement if any (usually not routine crystalloid replacement of full volume in uncomplicated outpatient phlebotomy, but some patients need cautious oral or IV fluid support—follow order and protocol)
• Access method (peripheral large-bore venipuncture is typical; some patients use existing VADs only if policy and device design allow therapeutic removal—many programs prefer dedicated peripheral sticks)

Principles:

1. Verify identity, consent/education, and order including hold parameters (e.g., do not phlebotomize if hemoglobin below threshold).
2. Baseline vital signs and symptom assessment (dizziness, chest pain, shortness of breath).
3. Large-bore peripheral access when possible to allow steady flow and reduce hemolysis/clotting in the collection set.
4. Aseptic technique equivalent to donation-style collection: skin antisepsis, closed collection bag or ordered device, secure tubing.
5. Remove the prescribed volume over a controlled time; do not “speed through” a unit in an unstable patient.
6. Monitor for vasovagal signs: pallor, diaphoresis, nausea, bradycardia or relative bradycardia with hypotension, yawning, visual gray-out.
7. Post-removal vitals, site care, and recovery period before ambulation.

Weight-based adjustments matter in smaller adults and in any patient with cardiovascular disease; never assume every adult tolerates a full unit.

Monitoring vital signs and recognizing complications

Hypovolemia and hemodynamic effects

Removing 450–500 mL acutely reduces circulating volume. Healthy outpatients often compensate; older adults, those on antihypertensives, or dehydrated patients may not. Signs of hypovolemia include tachycardia, hypotension, dizziness, weakness, and delayed capillary refill. Compare to baseline; a “normal” heart rate of 90 may be significant if the patient’s baseline was 60.

Syncope and vasovagal reactions

Vasovagal syncope is among the most common acute complications. Prodrome includes warmth, nausea, tunnel vision, and sweating. Immediate actions:

• Stop the draw; keep the patient safe from falls
• Supine position; elevate legs if protocol allows and no contraindication
• Airway protection if loss of consciousness; call for help if prolonged or seizure-like activity
• Cold compress, reassurance, monitored recovery
• Document event; notify provider; do not rush the patient to standing or driving

Delayed syncope can occur after leaving the chair—observe per policy and teach patients not to leave until cleared.

Other complications

• Hematoma or bleeding at the site (especially if on anticoagulants—apply prolonged pressure)
• Nerve injury symptoms (sharp electric pain, persistent paresthesia)—stop and evaluate
• Anemia symptoms from over-frequent removal (fatigue, dyspnea on exertion)—flag for schedule review
• Iron deficiency as an intended intermediate state in hemochromatosis treatment, but excessive anemia is harmful
• Rare arterial puncture or serious cardiovascular events—emergency response

Iron studies and laboratory partnership

Therapeutic programs coordinate CBC, ferritin, transferrin saturation, and sometimes liver enzymes or other disease-specific labs. Nursing responsibilities:

• Ensure required labs are drawn on schedule (sometimes a small diagnostic sample is taken at the same visit—still label as diagnostic volume separate from the therapeutic bag)
• Recognize hold criteria (low Hb/Hct, active infection, pregnancy considerations per specialty, unstable vitals)
• Educate that ferritin falls gradually; one session does not “cure” iron overload
• For PV, emphasize hematocrit targets and thrombosis risk reduction rather than ferritin alone

Post-procedure care and teaching

After therapeutic phlebotomy:

1. Apply firm pressure to the venipuncture site, then a pressure dressing as needed; instruct the patient to avoid heavy lifting with that arm for several hours per protocol.
2. Oral fluids and light snack when not NPO or fluid-restricted, unless contraindicated.
3. Slow position changes—sit before stand; stand with assistance if lightheaded.
4. Activity: avoid strenuous exercise, hot showers/saunas, or alcohol the same day if protocol advises, because vasodilation can worsen hypotension.
5. Warning signs to report: persistent bleeding, expanding bruising, syncope, chest pain, severe dizziness, or neurologic symptoms.
6. Medications: remind patients that antihypertensives may increase post-phlebotomy hypotension risk; they should follow their prescriber’s advice on timing doses around procedures.
7. Return schedule and lab follow-up for the chronic plan (induction vs maintenance).

Document volume removed, patient tolerance, vitals, site condition, and teaching. If the full ordered volume could not be completed, record actual volume and reason.

Special populations and practical constraints

• First-time patients need more education and closer observation for vasovagal risk.
• Difficult venous access may require ultrasound-guided peripheral access by a qualified clinician; do not force repeated traumatic sticks that create hematomas and delay therapy.
• Existing central lines are not automatically preferred for large-volume therapeutic removal; infection risk, lumen size, and policy often favor peripheral access. If a VAD is used under protocol, apply the same asepsis and monitoring standards.
• Outpatient vs inpatient: inpatients may have more comorbidities—verify fluid status and competing orders (e.g., active bleeding, sepsis).

High-yield exam comparisons

Stem A: “Remove 500 mL whole blood for hematocrit 54% in polycythemia vera.” → Therapeutic phlebotomy; monitor VS; post-care for hypovolemia/syncope; goal-directed volume.

Stem B: “Obtain CMP and CBC from PICC; TPN infusing.” → Diagnostic sampling; waste/dead-space management; not a unit removal.

Stem C: “Hemochromatosis, ferritin still high after weekly sessions.” → Expect continued induction phlebotomy per order and iron study monitoring—not a single diagnostic stick.

Stem D: “Secondary erythrocytosis from uncontrolled hypoxia.” → Question whether phlebotomy alone is appropriate; underlying cause matters; follow order but understand clinical context.

Safety culture and scope

Therapeutic phlebotomy is an ordered treatment within nursing and facility competency frameworks. Practice within protocol, complete competency validation, and escalate when vitals are unstable, hold parameters are met, or the patient refuses. Never substitute a large therapeutic removal for a missed diagnostic lab draw, and never treat a bag of removed blood as a laboratory specimen unless specifically collected and labeled for that dual purpose under protocol.

If you can state the major indications, volume/monitoring principles, iron-study role, complication response, and the diagnostic-versus-therapeutic distinction, you are prepared for Domain 1C therapeutic phlebotomy items and for safe bedside practice alongside diagnostic sampling skills from the previous section.